Literature DB >> 18317503

C-reactive protein is neither a marker nor a mediator of atherosclerosis.

Mark B Pepys1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18317503     DOI： 10.1038/ncpneph0778

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN： 1745-8323


× No keyword cloud information.
  9 in total

1.  Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.

Authors:  Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

2.  Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Authors:  Paul Elliott; John C Chambers; Weihua Zhang; Robert Clarke; Jemma C Hopewell; John F Peden; Jeanette Erdmann; Peter Braund; James C Engert; Derrick Bennett; Lachlan Coin; Deborah Ashby; Ioanna Tzoulaki; Ian J Brown; Shahrul Mt-Isa; Mark I McCarthy; Leena Peltonen; Nelson B Freimer; Martin Farrall; Aimo Ruokonen; Anders Hamsten; Noha Lim; Philippe Froguel; Dawn M Waterworth; Peter Vollenweider; Gerard Waeber; Marjo-Riitta Jarvelin; Vincent Mooser; James Scott; Alistair S Hall; Heribert Schunkert; Sonia S Anand; Rory Collins; Nilesh J Samani; Hugh Watkins; Jaspal S Kooner
Journal:  JAMA       Date:  2009-07-01       Impact factor: 56.272

3.  Does C-reactive protein contribute to atherothrombosis via oxidant-mediated release of pro-thrombotic factors and activation of platelets?

Authors:  Zhuo Zhang; Yan Yang; Michael A Hill; Jianbo Wu
Journal:  Front Physiol       Date:  2012-11-16       Impact factor: 4.566

4.  No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice.

Authors:  Daniel Teupser; Odile Weber; Tata Nageswara Rao; Kristina Sass; Joachim Thiery; Hans Jörg Fehling
Journal:  J Biol Chem       Date:  2010-12-11       Impact factor: 5.157

Review 5.  C-reactive protein in human atherogenesis: facts and fiction.

Authors:  Oliver Zimmermann; Kefei Li; Myron Zaczkiewicz; Matthias Graf; Zhongmin Liu; Jan Torzewski
Journal:  Mediators Inflamm       Date:  2014-04-01       Impact factor: 4.711

6.  "First in Man": Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction.

Authors:  Wolfgang Ries; Ahmed Sheriff; Franz Heigl; Oliver Zimmermann; Christoph D Garlichs; Jan Torzewski
Journal:  Case Rep Cardiol       Date:  2018-11-06

7.  Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study.

Authors:  Qian Zhuang; Chong Shen; Yanchun Chen; Xianghai Zhao; Pengfei Wei; Junxiang Sun; Yanni Ji; Xiaotian Chen; Song Yang
Journal:  BMC Med Genet       Date:  2019-11-06       Impact factor: 2.103

8.  Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS).

Authors:  Myron Zaczkiewicz; Katharina Kostenzer; Matthias Graf; Benjamin Mayer; Oliver Zimmermann; Jan Torzewski
Journal:  J Clin Med       Date:  2022-03-22       Impact factor: 4.241

Review 9.  Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons.

Authors:  Jan Torzewski; Patrizia Brunner; Wolfgang Ries; Christoph D Garlichs; Stefan Kayser; Franz Heigl; Ahmed Sheriff
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.